231 related articles for article (PubMed ID: 35888123)
1. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury.
Gîrleanu I; Trifan A; Huiban L; Muzîca C; Petrea OC; Sîngeap AM; Cojocariu C; Chiriac S; Cuciureanu T; Costache II; Stanciu C
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888123
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.
Patel SS; Nabi E; Guzman L; Abbate A; Bhati C; Stravitz RT; Reichman T; Matherly SC; Driscoll C; Lee H; Luketic VA; Sterling RK; Sanyal AJ; Patel V; Levy M; Siddiqui MS
Liver Transpl; 2018 Mar; 24(3):333-342. PubMed ID: 29328556
[TBL] [Abstract][Full Text] [Related]
3. Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart-Kidney Team-Based Approach.
Shroff GR; Carlson MD; Mathew RO
Eur Cardiol; 2021 Feb; 16():e48. PubMed ID: 34950244
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
An J; Shim JH; Kim SO; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Circulation; 2014 Oct; 130(16):1353-62. PubMed ID: 25095888
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery disease and its risk factors in patients presenting for liver transplantation.
Gologorsky E; Pretto EA; Fukazawa K
J Clin Anesth; 2013 Dec; 25(8):618-23. PubMed ID: 23994032
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and the coronary artery disease.
Treeprasertsuk S; Lopez-Jimenez F; Lindor KD
Dig Dis Sci; 2011 Jan; 56(1):35-45. PubMed ID: 20464495
[TBL] [Abstract][Full Text] [Related]
7. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
9. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis.
Li B; Zhang C; Zhan YT
Can J Gastroenterol Hepatol; 2018; 2018():2784537. PubMed ID: 30065915
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
Kadayifci A; Tan V; Ursell PC; Merriman RB; Bass NM
J Hepatol; 2008 Oct; 49(4):595-9. PubMed ID: 18662837
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery disease in patients with liver cirrhosis.
Kalaitzakis E; Rosengren A; Skommevik T; Björnsson E
Dig Dis Sci; 2010 Feb; 55(2):467-75. PubMed ID: 19242795
[TBL] [Abstract][Full Text] [Related]
13. Detection and treatment of coronary artery disease in liver transplant candidates.
Keeffe BG; Valantine H; Keeffe EB
Liver Transpl; 2001 Sep; 7(9):755-61. PubMed ID: 11552207
[TBL] [Abstract][Full Text] [Related]
14. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
Chen Q; Li Q; Li D; Chen X; Liu Z; Hu G; Wang J; Ling W
Atherosclerosis; 2020 Apr; 299():45-52. PubMed ID: 32240838
[TBL] [Abstract][Full Text] [Related]
15. The relationship between coronary artery disease and cardiovascular events early after liver transplantation.
Patel SS; Lin FP; Rodriguez VA; Bhati C; John BV; Pence T; Siddiqui MB; Sima AP; Abbate A; Reichman T; Siddiqui MS
Liver Int; 2019 Jul; 39(7):1363-1371. PubMed ID: 30848862
[TBL] [Abstract][Full Text] [Related]
16. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation.
Gill MG; Majumdar A
World J Hepatol; 2020 Dec; 12(12):1168-1181. PubMed ID: 33442446
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery disease: Are men and women created equal?
Blum A; Blum N
Gend Med; 2009 Sep; 6(3):410-8. PubMed ID: 19850237
[TBL] [Abstract][Full Text] [Related]
18. 64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(11):1-44. PubMed ID: 23074388
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
20. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
Mann JP; Carter P; Armstrong MJ; Abdelaziz HK; Uppal H; Patel B; Chandran S; More R; Newsome PN; Potluri R
PLoS One; 2020; 15(10):e0241357. PubMed ID: 33108366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
